Evidence map›Paper›PMID 35213982›Full record

ArticlePharmaceutics2022

Plasminogen-Loaded Fibrin Scaffold as Drug Delivery System for Wound Healing Applications.

Tamer Al Kayal, Marianna Buscemi, Aida Cavallo, Ilenia Foffa, Giorgio Soldani, Paola Losi

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Glutaraldehyde Cross-Linking of Salt-Induced Fibrinogen Hydrogels.ACS biomaterials science & engineering · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tamer Al KayalInstitute of Clinical Physiology, National Research Council (CNR), 54100 Massa, Italy.
Marianna BuscemiInstitute of Clinical Physiology, National Research Council (CNR), 54100 Massa, Italy.
Aida CavalloInstitute of Clinical Physiology, National Research Council (CNR), 54100 Massa, Italy.
Ilenia FoffaInstitute of Clinical Physiology, National Research Council (CNR), 54100 Massa, Italy.
Giorgio SoldaniInstitute of Clinical Physiology, National Research Council (CNR), 54100 Massa, Italy.
Paola LosiInstitute of Clinical Physiology, National Research Council (CNR), 54100 Massa, Italy.ORCID 0000-0002-1350-8626
Istituto di Fisiologia Clinica · ITScuola Superiore Sant'Anna · IT

Funding

Kedrion Biopharma S.p.A. (Castelvecchio Pascoli, Lucca, Italy) Ulcer-Care Project
6 · The paper itself

Abstract

Plasminogen is a protein involved in intravascular and extravascular fibrinolysis, as well as in wound healing, cell migration, tissue formation and angiogenesis. In recent years its role in healing of tympanic perforations has been demonstrated in plasminogen deficient mice. The aim of this work was to fabricate a fibrin-based drug delivery system able to provide a local and sustained release of plasminogen at the wound site. Initially, the biological activity of plasminogen was evaluated by in vitro experiments on cell cultures. A metabolic assay (MTT) was carried out on L929 mouse fibroblast to determine the concentration that does not affect cell viability, which turned out to be 64 nM. The effect of plasminogen on cell migration was evaluated through a scratch test on human keratinocytes: cells treated with 64 nM plasminogen showed faster scratch closure than in complete medium. Fibrin scaffold loaded with plasminogen was fabricated by a spray process. SEM analysis showed the typical nano-fibrillar structure of a fibrin scaffold. Tensile tests highlighted significantly higher value of the ultimate stress and strain of fibrin scaffold with respect to fibrin clot. The in-vitro release kinetic showed an initial plasminogen burst, after that the release slowed, reaching a plateau at 7 days. Plasminogen-loaded fibrin scaffold applied in full-thickness diabetic mouse lesions showed a significantly higher closure rate at 14 days than scaffold used as a reference material. Histological analysis demonstrated an improved reepithelization and collagen deposition in granulation tissue in mouse treated with plasminogen-loaded fibrin scaffold in comparison to unloaded fibrin scaffold. The obtained results demonstrated the suitability of the fibrin scaffold loaded with plasminogen as drug delivery system and suggest its use in wound healing applications, such as for the treatment of chronic diabeticulcers.

Indexed as

diabetic micefibrin scaffoldhistological analysisplasminogenscratch testwound healing

Identifiers

PMID35213982
PMCPMC8879571
OpenAlexW4207021776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.